Treatment For Early Onset Parkinson's Disease

Treatment For Young Onset Parkinsons

Early Onset Idiopathic Parkinsons Disease

To date, there is no known cure or way to prevent Parkinsons disease. However, research is ongoing and remarkable progress is being made. There is very real hope that the causes, whether genetic, environmental, or some combination of the two, will soon be identified and the precise effects of these causes on brain function will be understood. Although there is no cure for the disease at this time, by identifying symptoms and determining a proper course of treatment, most people with the disease are able to remain active and lead fulfilling lives.

Are there doctors who specialize in Parkinsons disease?

Doctors who are specially trained to diagnose and treat conditions of the brain and nervous system are called neurologists. Some neurologists have a subspecialty in movement disorders and work extensively with patients who have Parkinsons disease and other similar conditions. These doctors also may have experience dealing with early onset Parkinsons symptoms. You can ask your physician if they have specific experience with younger patients, or whether they can refer you to a doctor who does.

How do I find a Parkinsons disease specialist?

Early Onset Resources

Employment information

How Is Young Onset Parkinsons Disease Diagnosed

Doctors diagnose young onset Parkinsons disease by reviewing your medical history and conducting a physical examination, including neurological tests.

However, it may take doctors longer to reach the diagnosis because young onset Parkinsons disease is less common than late onset. They may recommend genetic testing.

Learn more about diagnosing Parkinsons disease.

Managing Your Symptoms With Medication

Almost all patients with Parkinsons disease eventually need to take medication to help with their motor symptoms. Several classes of medications are available and can be viewed here. Carbidopa/Levodopa remains the most effective symptomatic therapy and is available in many strengths and formulations. It also may be used in combination with other classes of medications including Dopamine Agonists, COMT Inhibitors, MAO Inhibitors, and Anticholinergic agents. Treatment is highly individualized and adjusted over time based on symptoms and side effects.

Don’t Miss: Do You Get Pain With Parkinson’s

How Soon After Treatment Will I Feel Better And How Long Will It Take To Recover

The time it takes to recover and see the effects of Parkinson’s disease treatments depends strongly on the type of treatments, the severity of the condition and other factors. Your healthcare provider is the best person to offer more information about what you can expect from treatment. The information they give you can consider any unique factors that might affect what you experience.

Treatment Options For Early Onset Parkinsons Disease

Parkinsons treatment aims to slow the diseases progression. Medication treatment options may include the following:

Levodopa is a chemical thats converted to dopamine in the brain. People with early onset Parkinsons may experience more negative side effects, such as involuntary movements.
MAO-B inhibitors can help reduce the breakdown of dopamine in the brain.
Catechol-O-methyltransferase inhibitors can help extend Levodopas effects on the brain.
Anticholinergics can help reduce tremors.
Amantadine may be used to improve muscle control and relieve stiffness.

Recommended Reading: Advanced Parkinson’s Home Care

Circumstances And Societal Engagement In Yopd And Implications For Management

In general, people with YOPD tend to have different family and societal engagements to those with late-onset PD. For example, most people diagnosed with YOPD will have a job, whereas some people with late-onset PD have already retired. Additionaly, it is not unusual that people with YOPD have young children , or may want to start a family.

What Did It Find

According to the UPDRS score, there was no difference in the progress of disease between the early-start group and the delayed-start group , .
The estimated rate of change in progression of the disease, a secondary outcome, was similar in both groups between 4 and 44 weeks .
Due to needing symptomatic relief, 87 people in the delayed-start group had levodopa before week 40.
The estimated rate of change in progression was faster between weeks 44 and 80 in the early-start group . This means starting levodopa earlier did not slow disease progression.
At 80 weeks, a similar proportion of participants were suffering complications, such as involuntary movements, from levodopa treatment .

Recommended Reading: Big Movements For Parkinson’s

Michael J Fox On How Accepting Parkinsons Diagnosis Changed His Perspective

I wasnt quite ready for that yet, she said. I immediately changed my diet. I immediately started exercising.

Exercise can help people with Parkinsons disease, James Beck, chief scientific officer of the Parkinsons Foundation, said.

Its not a cure-all, but it does wonders to help to manage symptoms, keeps people moving, which is really important, helps maintain muscle strength, he told TODAY. Its a rising tide that raises all boats helping people to live a better life.

Day did eventually start taking medication and her symptoms waned. But it was tough being so young and having a condition often associated with older people.

I didnt know anybody young and that was really hard, she said. I dreamed of having one friend or somebody that had my situation.

After a year of searching, she found someone with young onset Parkinsons disease. Then she met another and she decided to start a Facebook group of people in the area with the condition.

Its grown organically at this point. Theres 40 something people and weve gotten together of times in person, Day said. The optimism and hope that I bring to situations is not as common as I thought and I have an opportunity to help people and I enjoy that.”

Tapering And Discontinuing Das

Parkinsons Disease: Symptoms and Treatment

Recommendation 5 Rationale

Adverse effects associated with DAs can lead to substantial impairments in psychosocial functioning, interpersonal relationships, and quality of life for the patient and caregivers. The consequences of medication-related adverse effects may be mitigated through adjustments to prescribed medications, including DAs, or through additional behavioral or pharmacologic interventions, if appropriate.

Patients may experience undesirable side effects when attempting to decrease dopaminergic medications, especially DAs, including dopamine agonist withdrawal syndrome or low mood and apathy. These side effects can make it difficult to taper or discontinue DAs. Staged reduction in dosing may reduce the severity of withdrawal symptoms and improve compliance with medication recommendations.

Recommendation 5 Statements

5a. Clinicians should recommend tapering or discontinuation of DAs if patients experience disabling medication-related adverse effects, including ICDs, EDS, sudden-onset sleep, cognitive impairment, or hallucinations .
5b. When DAs must be discontinued due to adverse effects, clinicians should monitor patients for symptoms of DAWS and, when possible, gradually decrease the dosage to minimize symptoms .

You May Like: Adaptive Silverware For Parkinsons

Also Check: Sugar And Parkinson’s Disease

What Tests Will Be Done To Diagnose This Condition

When healthcare providers suspect Parkinsons disease or need to rule out other conditions, various imaging and diagnostic tests are possible. These include:

Positron emission tomography scan.

New lab tests are possible

Researchers have found possible ways to test for possible indicators or Parkinsons disease. Both of these new tests involve the alpha-synuclein protein but test for it in new, unusual ways. While these tests cant tell you what conditions you have because of misfolded alpha-synuclein proteins, that information can still help your provider make a diagnosis.

The two tests use the following methods.

Spinal tap. One of these tests looks for misfolded alpha-synuclein proteins in cerebrospinal fluid, which is the fluid that surrounds your brain and spinal cord. This test involves a spinal tap , where a healthcare provider inserts a needle into your spinal canal to collect some cerebrospinal fluid for testing.
Skin biopsy. Another possible test involves a biopsy of surface nerve tissue. A biopsy includes collecting a small sample of your skin, including the nerves in the skin. The samples come from a spot on your back and two spots on your leg. Analyzing the samples can help determine if your alpha-synuclein has a certain kind of malfunction that could increase the risk of developing Parkinsons disease.

What Is Parkinsons Disease

Parkinsons disease is a condition where a part of your brain deteriorates, causing more severe symptoms over time. While this condition is best known for how it affects muscle control, balance and movement, it can also cause a wide range of other effects on your senses, thinking ability, mental health and more.

You May Like: When Is Parkinson’s Diagnosed

Can You Be Too Young To Get Parkinsons Disease

The majority of people who get Parkinsons Disease are over the age of 60. However, 10 to 20 percent of the 60,000 people diagnosed every year in the United States are under age 50 and about half of those are diagnosed before age 40.

Rebecca Gilbert, American Parkinson Disease Association

Because PD is typically associated with older individuals, the disease is often overlooked in younger people, according to Rebecca Gilbert, MD, PhD, Chief Scientific Officer for the American Parkinson Disease Association . She said that that can lead to many being undiagnosed or misdiagnosed for extended periods of time.

We dont yet have a prevention or cure for Parkinsons, so a later diagnosis does not mean missing out on any curative therapies, she said. However, knowing you have the disease as early as possible gives you a leg up in terms of educating yourself, understanding how the disease progresses and learning the benefits of neuroprotective exercises that can also ease symptoms.

Tips For Caring For Someone With Parkinsons Disease

Caring for a loved one with early onset Parkinsons can be difficult. If youre a caregiver for someone with this condition, its important that you remember your own emotional and physical health.

Not only are you dealing with a difficult diagnosis, youre also managing an increased number of responsibilities. Burnout is common in caregivers, so make sure youre checking in with your own needs.

The Michael J. Fox Foundation Center for Parkinsons Research recommends these tips for caregivers:

Don’t Miss: How To Get A Service Dog For Parkinson’s

Prescription Pattern Of Anti

Ten types of anti-PD drugs were identified as monotherapy or polytherapy in the population, namely, L-DOPA/benserazide, L-DOPA/carbidopa, pramipexole, ropinirole, piribedil, bromocriptine, entacapone, selegiline, trihexyphenidyl, and amantadine. In all prescriptions, about 86%95% were prescribed by neurologists. The percentage of patients who were prescribed each type of anti-PD drug based on the year, from 2014 to 2019, is shown in Figure 1. L-DOPA/benserazide was the most commonly prescribed anti-PD drug in the past 6 years, with an average percentage of over 30% for all anti-PD drugs. Pramipexole, selegiline, and trihexyphenidyl, followed by L-DOPA/benserazide, accounted for over 10% of all anti-PD drugs. Other drugs were prescribed in < 10% of patients with YOPD each year. Similarly, L-DOPA/benserazide , pramipexole , selegiline and trihexyphenidyl were also the most commonly prescribed for these patients at their first medical visit.

FIGURE 1. The percentage and count of patients with each prescribed anti-Parkinsons disease drug from 2014 to 2019 based on each year.

FIGURE 2. The percentage and number of patients being prescribed different anti-Parkinsons disease drugs from 2014 to 2019.

FIGURE 3. The percentage and number of patients on monotherapy of anti-Parkinsons disease drugs from 2014 to 2019.

FIGURE 4. The percentage and number of patients being prescribed two types of anti-Parkinsons disease drugs from 2014 to 2019.

Study Screening And Selection Criteria

Types of Participants

We included studies of participants with PD in the early stages .

Types of Interventions

We included studies of DAs, levodopa, monoamine oxidase type B inhibitors, and catechol-O-methyltransferase inhibitors to treat motor symptoms of PD in the early stages of the disease.

Comparison Group

We included studies using active comparators only.

Types of Studies

For clinical questions 1 through 6, we included only randomized controlled trials. For clinical questions 7 and 8, we included randomized controlled trials, population-based epidemiologic studies, and prospective cohort studies.

Types of Outcome Measures

The preferred outcome measure was the Unified Parkinsons Disease Rating Scale part III, which measures motor symptoms. To determine the change in motor symptoms, the authors calculated the raw mean difference between scores on the UPDRS part III at baseline and at follow-up. To determine the change in dyskinesia, hallucinations, adverse event related discontinuation, and impulse control disorders , the risk differences were calculated.

Also Check: Parkinson’s And Mouth Problems

How Successful Is Ayurvedic Treatment For Parkinsons Disease

At Sukhayu, we are treating the cases of Parkinsons without using Dopamine. This is moreover like talking about sunlight without sun for many of us. But this is true because Ayurveda doesnt recommend or thinks about dopamines!

This is because we know that the nervous system needs the balancing of things, not just some external supply of dopamines.

In name of Ayurveda, the same mistake is made again and again. We kept on working on the tremors through Ayurveda. Secondly, the mistake is to use herbs that carry dopamine. Then what is the difference between the Ayurvedic and Allopathic approaches?

Undertreatment of Vaidya Pardeep, there are many patients. These patients come from every part of the globe and getting proper results. We are able to give these results, repetitively.

However, we have only 82% results with patients. We know these mean a lot in a condition similar to Parkinsons. This 82% are the cases where we had withdrawn all medicines and the patient is leading a normal life. But we are working hard to make it possible with the maximum number of patients.

At Sukhayu we treat diseases of the nervous system successfully: Multiple Sclerosis

Symptoms Of Parkinsons Disease

Early Parkinson’s Disease

Parkinsons has four main symptoms:

Tremor in hands, arms, legs, jaw, or head
Muscle stiffness, where muscle remains contracted for a long time
Slowness of movement
Impaired balance and coordination, sometimes leading to falls

Other symptoms may include:

The symptoms of Parkinsons and the rate of progression differ among individuals. Early symptoms of this disease are subtle and occur gradually. For example, people may feel mild tremors or have difficulty getting out of a chair. They may notice that they speak too softly, or that their handwriting is slow and looks cramped or small. Friends or family members may be the first to notice changes in someone with early Parkinsons. They may see that the persons face lacks expression and animation, or that the person does not move an arm or leg normally.

People with Parkinson’s disease often develop a parkinsonian gait that includes a tendency to lean forward take small, quick steps and reduce swinging their arms. They also may have trouble initiating or continuing movement.

Symptoms often begin on one side of the body or even in one limb on one side of the body. As the disease progresses, it eventually affects both sides. However, the symptoms may still be more severe on one side than on the other.

Is Parkinsons Disease Inherited

Scientists have discovered gene mutations that are associated with Parkinsons disease.

There is some belief that some cases of early-onset Parkinsons disease disease starting before age 50 may be inherited. Scientists identified a gene mutation in people with Parkinsons disease whose brains contain Lewy bodies, which are clumps of the protein alpha-synuclein. Scientists are trying to understand the function of this protein and its relationship to genetic mutations that are sometimes seen in Parkinsons disease and in people with a type of dementia called Lewy body dementia.

Several other gene mutations have been found to play a role in Parkinsons disease. Mutations in these genes cause abnormal cell functioning, which affects the nerve cells ability to release dopamine and causes nerve cell death. Researchers are still trying to discover what causes these genes to mutate in order to understand how gene mutations influence the development of Parkinsons disease.

Scientists think that about 10% to 15% of persons with Parkinsons disease may have a genetic mutation that predisposes them to development of the disease. There are also environmental factors involved that are not fully understood.

How Is It Treated And Is There A Cure

For now, Parkinsons disease is not curable, but there are multiple ways to manage its symptoms. The treatments can also vary from person to person, depending on their specific symptoms and how well certain treatments work. Medications are the primary way to treat this condition.

A secondary treatment option is a surgery to implant a device that will deliver a mild electrical current to part of your brain . There are also some experimental options, such as stem cell-based treatments, but their availability often varies, and many aren’t an option for people with Parkinsons disease.

Recommended Reading: Assisted Living For Parkinson’s Patients

Antipsychotics Can Trigger Pd

When you have Parkinsons, your brain doesnt make enough dopamine, says Dr. Clar. Thats the feel-good chemical thats also responsible for sending signals from your brain to the muscles in your body that control movement. Antipsychotic meds block dopamine receptors in the brain. So, even though your brain might still be producing dopamine, it cant send signals the right way, thanks to those drugs. The result is that a person can have the physical symptoms of Parkinsons but not actually have Parkinsons, says Dr. Clar. Some of that confusion could have muddied the results of the study, too.

Also Check: Stretches For Parkinsons Patients

Young Onset Parkinsons Disease: A Modern And Tailored Approach

Issue title: Special Issue: Clinical management of Parkinsons disease: Essentials and new developments

Guest editors: Bastiaan R. Bloem and Patrik Brundin

Article type: Review Article

Affiliations: Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Center of Expertise for Parkinson and Movement Disorders, Nijmegen, The Netherlands | Department of Rehabilitation, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Center of Expertise for Parkinson and Movement Disorders Nijmegen, The Netherlands | Department of Rehabilitation, Sint Maartenskliniek, Nijmegen, The Netherlands

Correspondence: Correspondence to: Bart Post, MD, PhD, Radboud University Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands. E-mail:

Keywords: Parkinsonss disease, young-onset, quality of life, work, caregiver, genetics, dystonia

DOI: 10.3233/JPD-202135

Journal: Journal of Parkinson’s Disease, vol. 10, no. s1, pp. S29-S36, 2020

Treatment For Early Onset Parkinson’s Disease